Published in Eur J Cancer on June 04, 2010
Identification of serum microRNA profiles in colon cancer. Br J Cancer (2013) 1.02
Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med (2013) 0.97
Population-based colorectal cancer screening: comparison of two fecal occult blood test. Front Pharmacol (2014) 0.86
Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: impact on colorectal cancer cases and deaths. Br J Cancer (2015) 0.84
Assessing knowledge and attitudes towards screening among users of Faecal Immunochemical Test (FIT). Health Expect (2013) 0.83
Face-to-face vs telephone pre-colonoscopy consultation in colorectal cancer screening; a randomised trial. Br J Cancer (2012) 0.80
Is There a Place for Screening Flexible Sigmoidoscopy? Curr Colorectal Cancer Rep (2012) 0.75
Cost-Effectiveness between Double and Single Fecal Immunochemical Test(s) in a Mass Colorectal Cancer Screening. Biomed Res Int (2016) 0.75
KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population. Oncol Lett (2017) 0.75
Free Fecal Immunochemical Test Disbursement in Eight Family Physician Offices. J Community Health (2015) 0.75
Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis. Onco Targets Ther (2017) 0.75
Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol (1998) 9.13
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut (2006) 9.03
Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst (2000) 3.92
Test-retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med (1994) 3.31
[Occult blood studies of the feces obsolete]. Ned Tijdschr Geneeskd (1996) 3.29
Nurse endoscopists perform colonoscopies according to the international standard and with high patient satisfaction. Endoscopy (2012) 3.27
Spatial and temporal variations of malaria epidemic risk in Ethiopia: factors involved and implications. Acta Trop (2003) 3.16
Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am J Gastroenterol (2009) 2.89
Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun (1996) 2.75
Colonoscopy perforation rate, mechanisms and outcome: from diagnostic to therapeutic colonoscopy. Endoscopy (2009) 2.70
Complications of single-balloon enteroscopy: a prospective evaluation of 166 procedures. Endoscopy (2010) 2.62
Short-term esophageal stenting in the management of benign perforations. Am J Gastroenterol (2010) 2.55
A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group. Am J Public Health (2000) 2.49
Double-balloon enteroscopy: indications, diagnostic yield, and complications in a series of 275 patients with suspected small-bowel disease. Endoscopy (2006) 2.43
Increasing incidence of Barrett's oesophagus in the general population. Gut (2005) 2.34
Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol (2001) 2.33
Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol (1999) 2.33
High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol (2010) 2.32
A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32
Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol (1997) 2.17
PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer (1996) 2.13
Female sex workers and unsafe sex in urban and rural Nyanza, Kenya: regular partners may contribute more to HIV transmission than clients. Trop Med Int Health (2007) 2.11
Effects of meteorological factors on epidemic malaria in Ethiopia: a statistical modelling approach based on theoretical reasoning. Parasitology (2004) 2.08
The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off. Aliment Pharmacol Ther (2014) 2.07
The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol (2009) 2.04
[Acute dysphasia: often there is a readily treatable cause]. Ned Tijdschr Geneeskd (2003) 2.03
A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc (2001) 2.03
Predicting mortality from cervical cancer after negative smear test results. BMJ (1992) 2.01
Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull World Health Organ (2002) 1.99
Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol (2012) 1.98
The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res (1999) 1.98
Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. Int J Technol Assess Health Care (1996) 1.95
Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis (2005) 1.95
Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer (2009) 1.93
Resolution of cutaneous inflammation after local elimination of macrophages. Nat Biotechnol (2000) 1.88
Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples. Hum Reprod (2006) 1.86
Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol (2010) 1.85
Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther (2009) 1.83
Optimal resource allocation in colonoscopy: timing of follow-up colonoscopies in relation to adenoma detection rates. Endoscopy (2013) 1.82
The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter (2007) 1.77
The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system. J Clin Epidemiol (1999) 1.77
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. J Antimicrob Chemother (1999) 1.73
Helicobacter pylori: a true carcinogen? Eur J Gastroenterol Hepatol (1998) 1.72
Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer (2008) 1.69
Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs). Aliment Pharmacol Ther (2010) 1.68
Forecasting malaria incidence from historical morbidity patterns in epidemic-prone areas of Ethiopia: a simple seasonal adjustment method performs best. Trop Med Int Health (2002) 1.67
Reliability and validity of the child health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Qual Life Res (2002) 1.64
Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol (2000) 1.62
Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol (1997) 1.62
Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection. Aliment Pharmacol Ther (1998) 1.61
Clinical outcome of progressive stenting in patients with anastomotic strictures after orthotopic liver transplantation. Endoscopy (2013) 1.61
Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors. Aliment Pharmacol Ther (2007) 1.59
Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcriptional level. Infect Immun (2001) 1.59
Three unusual repair deficiencies associated with transcription factor BTF2(TFIIH): evidence for the existence of a transcription syndrome. Cold Spring Harb Symp Quant Biol (1994) 1.57
Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing. BJOG (2012) 1.57
Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother (1998) 1.56
Prevalence of autoimmune pancreatitis and other benign disorders in pancreatoduodenectomy for presumed malignancy of the pancreatic head. Dig Dis Sci (2012) 1.56
Comparative genomic hybridisation. Mol Pathol (1999) 1.56
Predictors of dose escalation of adalimumab in a prospective cohort of Crohn's disease patients. Aliment Pharmacol Ther (2011) 1.53
Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol (2001) 1.50
A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer (1998) 1.49
[Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study]. Ned Tijdschr Geneeskd (2005) 1.48
Sequential therapy; a new treatment for Helicobacter pylori infection. But is it ready for general use? Dig Liver Dis (2004) 1.47
Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology (2007) 1.47
The number of retrieved oocytes does not decrease during consecutive gonadotrophin-stimulated IVF cycles. Hum Reprod (2004) 1.46
Endocervical status is not predictive of the incidence of cervical cancer in the years after negative smears. Am J Clin Pathol (2001) 1.45
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer (2009) 1.44
Comparison of magnetic resonance enteroclysis and capsule endoscopy with balloon-assisted enteroscopy in patients with obscure gastrointestinal bleeding. Endoscopy (2012) 1.44
The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy (2012) 1.44
[Double-balloon enteroscopy of the small intestine]. Ned Tijdschr Geneeskd (2007) 1.43
Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF. J Assist Reprod Genet (2005) 1.42
Medium-term cost analysis of breast reconstructions in a single Dutch centre: a comparison of implants, implants preceded by tissue expansion, LD transpositions and DIEP flaps. J Plast Reconstr Aesthet Surg (2011) 1.41
Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod (2009) 1.40
[Diagnosis and treatment of esophageal cancer in the Netherlands: wide variation in the second line]. Ned Tijdschr Geneeskd (2003) 1.40
Hemospray in the treatment of upper gastrointestinal hemorrhage in patients on antithrombotic therapy. Endoscopy (2012) 1.40
Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion. Gastroenterology (1999) 1.40
[The consequences of postponing pregnancy]. Ned Tijdschr Geneeskd (2007) 1.39
[Incidental cystic structures in the upper abdomen: to remove or not to remove?]. Ned Tijdschr Geneeskd (2006) 1.39
Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections. Int J Cancer (1997) 1.38